Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification

Article Type
Changed
Tue, 09/25/2018 - 14:23
Display Headline
Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification
Article PDF
Author and Disclosure Information

Heather L. Gornik, MD, MHS
Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Mark A. Creager, MD
Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

Correspondence: Heather L. Gornik, MD, MHS, Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, S60, Cleveland, OH 44195; [email protected]

Dr. Gornik reported that she has received research grant support from Pfizer.

Dr. Creager reported that he has received consulting fees from Genzyme, Sigma Tau, Vasogen, and Wyeth, and has received consulting fees as well as honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

Publications
Page Number
S30-S37
Author and Disclosure Information

Heather L. Gornik, MD, MHS
Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Mark A. Creager, MD
Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

Correspondence: Heather L. Gornik, MD, MHS, Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, S60, Cleveland, OH 44195; [email protected]

Dr. Gornik reported that she has received research grant support from Pfizer.

Dr. Creager reported that he has received consulting fees from Genzyme, Sigma Tau, Vasogen, and Wyeth, and has received consulting fees as well as honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

Author and Disclosure Information

Heather L. Gornik, MD, MHS
Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Mark A. Creager, MD
Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

Correspondence: Heather L. Gornik, MD, MHS, Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, S60, Cleveland, OH 44195; [email protected]

Dr. Gornik reported that she has received research grant support from Pfizer.

Dr. Creager reported that he has received consulting fees from Genzyme, Sigma Tau, Vasogen, and Wyeth, and has received consulting fees as well as honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

Article PDF
Article PDF
Page Number
S30-S37
Page Number
S30-S37
Publications
Publications
Article Type
Display Headline
Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification
Display Headline
Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification
Citation Override
Cleveland Clinic Journal of Medicine 2006 October;73(suppl 4):S30-S37
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media